Pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. The platform, called iSPERSE (inhaled small particles easily respirable and emitted), represents a new paradigm in inhaled drug delivery based on unique properties: dense, high drug load engineered particles with highly efficient dispersibility and delivery to the airways. The iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance.
Location: United States, Massachusetts, Lexington
Member count: 11-50
Total raised: $19.7M
Investors 4
| Date | Name | Website |
| - | 5AM Ventur... | 5amventure... |
| 17.07.2021 | ARCH Ventu... | archventur... |
| - | Hercules C... | htgc.com |
| - | Altitude L... | altitudels... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 15.08.2011 | - | $14M | - | finsmes.co... |
| 14.12.2010 | Grant | $5.7M | - | massdevice... |
Mentions in press and media 22
| Date | Title | Description | Category | Author | Source |
| 18.12.2021 | Pulmatrix ... | Pulmatrix Announces Closing of... | - | - | marketscre... |
| 18.12.2021 | Pulmatrix ... | LEXINGTON, Mass., Dec. 17, 202... | - | - | marketscre... |
| 16.12.2021 | Pulmatrix ... | Pulmatrix Announces $6.75 Mill... | - | - | marketscre... |
| 15.12.2021 | Pulmatrix ... | LEXINGTON, Mass., Dec. 15, 202... | - | - | marketscre... |
| 10.08.2021 | Pulmatrix ... | LEXINGTON, Mass., Aug. 10, 2... | - | - | prnewswire... |
| 27.07.2021 | Pulmatrix ... | LEXINGTON, Mass., July 27, 2... | - | - | prnewswire... |
| 15.04.2021 | Pulmatrix ... | LEXINGTON, Mass., April 15, ... | - | - | prnewswire... |
| 12.04.2021 | Corrected:... | LEXINGTON, Mass., April 12, ... | - | - | prnewswire... |
| 23.03.2021 | Pulmatrix ... | LEXINGTON, Mass., March 23, ... | - | - | prnewswire... |
| 04.03.2021 | Pulmatrix ... | LEXINGTON, Mass., March 4, 2... | - | - | prnewswire... |
Show more